Chris Uyehara
cmuyehara.bsky.social
Chris Uyehara
@cmuyehara.bsky.social
Postdoc in Apostolou Lab | Weill Cornell Medicine |
Ph.D, UNC Chapel Hill, McKay Lab
http://cmuyehara.com

Carpe Diem. Carpe Annum. Carpe Everything.
Reposted by Chris Uyehara
I'm really happy to announce that my two main postdoctoral works have been published in the same issue of Developmental Cell! First, the final form of the mouse cortical organoid protocol (tinyurl.com/bddfmx8n), which I recently presented at Development presents (tinyurl.com/36udcpme) and…
tinyurl.com
August 27, 2025 at 4:25 PM
Reposted by Chris Uyehara
Epigenetics Update - Three-dimensional regulatory hubs support oncogenic programs in glioblastoma bit.ly/4iDk8Ec

Howard A. Fine and Effie Apostolou (Weill Cornell Medicine) reporting in Mol Cell

#Epigenetics #GBM
---

High-resolution insights without cell sorting at epigenometech.com
March 27, 2025 at 2:28 PM
Reposted by Chris Uyehara
Our work on the regulation is out www.cell.com/stem-cell-re...! Congrats to our collaborators in the Vierbuchen and Mezey labs. It turns out that genetic variation has to be very much considered if you want to harness stem cells safely in biomedicine. #pluripotency #epigenetics #stemcells
Genetic variation modulates susceptibility to aberrant DNA hypomethylation and imprint deregulation in naive pluripotent stem cells
Pluripotent stem cells are susceptible to acquiring detrimental epigenetic abnormalities, posing a hurdle to their safe use in biomedical applications. Using pluripotent cells with defined genetic bac...
www.cell.com
March 13, 2025 at 8:41 PM
Reposted by Chris Uyehara
Post-mitotic transcriptional activation and 3D regulatory interactions show locus- and differentiation-specific sensitivity to cohesin depletion https://www.biorxiv.org/content/10.1101/2025.02.13.638153v1
February 15, 2025 at 7:17 AM
Reposted by Chris Uyehara
And a second study in collaboration with Dr. Fine, led by
the talented Sarah Breves, Dafne Di Giammartino and Alex Polyzos revealing the role of hyperconnected 3D hubs in controlling broader oncogenic programs in glioblastoma and other cancers. www.biorxiv.org/content/10.1...
December 20, 2024 at 10:18 PM
Kaushiki and I are excited to share our preprint about fate restriction in pluripotent cells! We show that EHMT2 counteracts the reactivation of clusters of totipotency genes by nucleating heterochromatin domains at LINE-1 repeats. 1/n

@efapostolou29.bsky.social and Stadtfeld Labs
#DevBio 🧬🖥️
December 20, 2024 at 6:36 PM